Quantum量子訊息有限公司
← 最新全球產業報告

Biochips Market

研究執行與發布:Coherent Market Insights · 發布日期 2026-05-18 · 152 頁
由量子訊息有限公司(Quantum Information)在台灣代理銷售與提供授權諮詢。

2026 年市場規模
USD 21,996.6 Mn
2033 年預估規模
USD 48,138.1 Mn
年複合成長率 CAGR
11.8%

以上數字由 Coherent Market Insights 於本報告中提出,量子訊息原樣引用。

出版商 Coherent Market Insights產業別 Healthcare & Life Sciences出版日期 2026-05-18頁數 152報告編號 CMI1146

授權報價

Single User Price$4,500 USD
Enterprise License$10,000 USD
洽詢購買 申請 Sample
完整報告名稱與涵蓋範圍
Biochips Market, By Type (DNA Microarray, Microfluidic Chip, Protein Microarray, and Others), By Technology (Microarrays and Microfluidics), By Application (Diagnosis, Drug Discovery and Development, Drug delivery, and Others), By End User (Biotechnological and Pharmaceutical companies, Hospitals, Diagnostic centers, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)

報告摘要

The global biochips market is estimated to be valued at USD 21,996.6 Mn in 2026 and is expected to reach USD 48,138.1 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 11.8% from 2026 to 2033. Biochips are known as miniature laboratories that are able to perform many biochemical reactions simultaneously and find applications in many fields like genomics, proteomics, diagnosis, drugs and personalized medicine. Some examples of technologies employed in the creation of these innovations are microarrays, microfluidics, and semiconductor-based analytical systems. These developments allow fast, efficient, and precise biological investigations. Increasing incidences of chronic diseases, need for early disease diagnosis, and adoption of precision medicines are some of the key factors influencing market growth across the globe. Moreover, the use of biochips in diagnosing infectious diseases, analyzing biomarkers of cancers, and conducting companion diagnostics has also increased their adoption considerably. In addition, technology developments in lab-on-a-chip systems, DNA microarrays, and biosensors are also encouraging innovations within the biochips industry. There has been an increasing tendency among pharmaceutical and biotech companies to utilize biochips in drug discovery research, toxicology, and biomarker identification in order to improve their research efficiency. In addition, growing investments in point-of-care diagnostics, miniaturized analysis equipment, and bioinformatics tools with artificial intelligence are also driving the market forward. Growing digitalization within the healthcare industry, genomic research initiatives, and decentralized diagnostics are other factors fueling industry expansion. However, some of the factors such as high costs associated with biochip development, complicated manufacturing procedures, and regulatory validation issues for diagnostic biochips may hamper market growth to some extent. Market Dynamics The global biochips market has gained traction due to the growing popularity of precise medicine, molecular diagnostics, and high throughput screening techniques among others. The biochips facilitate multi-parameter analysis of biological data, thus making them very important in genomics, proteomics, disease diagnosis, and drug discovery. The increasing cases of chronic diseases, the rising need for disease early diagnosis, and increased investment in personalized medical care is fueling the growth of the biochips market. Furthermore, the developments of microfluidics, biosensing technology, and semiconductor integration have made it possible to achieve higher efficiencies and increased miniaturization in biochips. Pharmaceutical and biotechnology companies are increasingly using biochips in their biomarker discovery, toxicity, and drug development process. However, there exist some challenges in the market that may limit its future growth during the forecast period. Such as, high costs of producing the biochips, the advanced instrument required, and integrating the software used is among the major challenges that hinder adoption in the market. Additionally, the regulatory process involved in validating the biochips used for diagnostics and other operations is another challenge that limits their commercialization and increases development costs. Some technical challenges associated with sample preparation, standardization of the data produced, and compatibility across different platforms affect the effectiveness of their use in some operations. However, increased investments in AI biological data analysis are expected to offer numerous growth opportunities in the market. Key Features of the Study • This report provides in-depth analysis of the global biochips market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global biochips market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Thermo Fisher Scientific, Agilent Technologies, Illumina, Bio-Rad Laboratories, QIAGEN, F. Hoffmann-La Roche, Abbott Laboratories, Standard BioTools, bioMérieux, and Revvity • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global biochips market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biochips market Market Segmentation • Type Insights (Revenue, USD Mn, 2021 - 2033) o DNA Microarray o Microfluidic Chip o Protein Microarray o Others • Technology Insights (Revenue, USD Mn, 2021 - 2033) o Microarrays o Microfluidics • Application Insights (Revenue, USD Mn, 2021 - 2033) o Diagnosis o Drug Discovery and Development o Drug delivery o Others • End User Insights (Revenue, USD Mn, 2021 - 2033) o Biotechnological and Pharmaceutical companies o Hospitals o Diagnostic centers o Others • Regional Insights (Revenue, USD Mn, 2021 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Thermo Fisher Scientific o Agilent Technologies o Illumina o Bio-Rad Laboratories o QIAGEN o Hoffmann-La Roche o Abbott Laboratories o Standard BioTools o bioMérieux o Revvity
目錄 Table of Contents
Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Global Biochips Market, By Type  Global Biochips Market, By Technology  Global Biochips Market, By Application  Global Biochips Market, By End User  Global Biochips Market, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Product Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Regulatory Scenario o Key Developments o Industry Trends 4. Global Biochips Market, By Type, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o DNA Microarray  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Microfluidic Chip  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Protein Microarray  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 5. Global Biochips Market, By Technology, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Microarrays  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Microfluidics  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 6. Global Biochips Market, By Application, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Diagnosis  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Drug Discovery and Development  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Drug delivery  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 7. Global Biochips Market, By End User, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Biotechnological and Pharmaceutical companies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Hospitals  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Diagnostic centers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 8. Global Biochips Market, By Region, 2021 - 2033, Value (USD Mn) o Introduction  Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)  Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn) o South Africa o North Africa o Central Africa 9. Competitive Landscape o Thermo Fisher Scientific  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Agilent Technologies  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Illumina  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Bio-Rad Laboratories  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o QIAGEN  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Hoffmann-La Roche  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Abbott Laboratories  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Standard BioTools  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o bioMérieux  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Revvity  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies 10. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 11. References and Research Methodology o References o Research Methodology o About us *Browse 32 market data tables and 28 figures on ‘Biochips Market' - Global forecast to 2033

提及公司

Thermo Fisher ScientificAgilent TechnologiesIlluminaBio-Rad LaboratoriesQIAGENHoffmann-La RocheAbbott LaboratoriesStandard BioToolsbioMérieuxRevvity

同分類最新報告(醫療與生命科學)

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們